KnowledgeBase

• Home
• Antimicrobials
• Microorganisms
• About Us
• Contact Us

• Search All
• Search by Antimicrobial
• Search by Microorganism
• 

Home › Search by Microorganism › Candida guilliermondii (IBA 155)

• Candida guilliermondii
• Candida guilliermondii (13003)
• Candida guilliermondii (337)
• Candida guilliermondii (555)
• Candida guilliermondii (ATCC 20216)
• Candida guilliermondii (ATCC 9058)
• Candida guilliermondii (ATCC 9390)
• Candida guilliermondii (B5050)
• Candida guilliermondii (C25)
• Candida guilliermondii (CBS 566)
• Candida guilliermondii (clinical isolate)
• Candida guilliermondii (CLY308)
• Candida guilliermondii (CLY346)
• Candida guilliermondii (esophageal candidiasis isolate)
• Candida guilliermondii (fluconazole-resistant)
• Candida guilliermondii (fluconazole-susceptible)
• Candida guilliermondii (IBA 155)
• Candida guilliermondii (IFM 46824)
• Candida guilliermondii (IFM 46826)
• Candida guilliermondii (IFM 5775)
• Candida guilliermondii (invasive candidiasis isolate)
• Candida guilliermondii (KCCM 50600)

This project is supported by TOKU-E which specializes in manufacturing ultra-pure antibiotics for a broad spectrum of biotechnology applications as well as for the pharmaceutical industry. TOKU-E is a global leader in biotechnology innovation, offering great benefits and applications to the biopharmaceutical and diagnostic industries as well as for biotechnology research communities.
Privacy Policy | Terms of Use
Knowledgebase version 1.8